Journal of Mass Spectrometry · 2013 · 21 citations · 15 references
PharmacyChemistryPharmaceutical AnalysisAnalytical ChemistryAnalytical ToxicologyMass Spectrometric AnalysisInstrumental AnalysisMass AnalyzersMass SpectrometryStructural ElucidationCharacteristic MassMass Spectrometric DetectionMass Spectrometric Drug AnalysisMass Spectrometric IdentificationMass Spectrometric QuantificationMass Spectrometric ScreeningMass Spectrometric Structural Elucidation
The isomers 4-methylethcathinone and N-ethylbuphedrone are substitutes for the recently banned drug mephedrone. We find that with conventional proton transfer reaction mass spectrometry (PTR-MS), it is not possible to distinguish between these two isomers, because essentially for both substances, only the protonated molecules are observed at a mass-to-charge ratio of 192 (C12 H18NO(+)). However, when utilising an advanced PTR-MS instrument that allows us to switch the reagent ions (selective reagent ionisation) from H3O(+) (which is commonly used in PTR-MS) to NO(+), O2(+) and Kr(+), characteristic product (fragment) ions are detected: C4H10N(+) (72 Da) for 4-methylethcathinone and C5 H12N(+) (86 Da) for N-ethylbuphedrone; thus, selective reagent ionisation MS proves to be a powerful tool for fast detection and identification of these compounds.
15
W. Lindinger, Armin Hansel, Alfons Jordan · International Journal of Mass Spectrometry and Ion Processes · 1998 · 1.7K citations